Classic pantothenate kinase-associated neurodegeneration

disease
On this page

Also known as NBIA1, classic formneurodegeneration with brain iron accumulation type 1, classic formPKAN, classic form

Summary

Classic pantothenate kinase-associated neurodegeneration (MONDO:0016304) is a disease. A subtype of pantothenate kinase-associated neurodegeneration — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Phenotypes (HPO): 28

Clinical features

Signs & symptoms

Clinical features (HPO)

28 HPO clinical features (Orphanet curated; top 28 by frequency):

HPO IDTermFrequency
HP:0001288Gait disturbanceVery frequent (80-99%)
HP:0000157Abnormality of the tongueFrequent (30-79%)
HP:0000510Rod-cone dystrophyFrequent (30-79%)
HP:0000543Optic disc pallorFrequent (30-79%)
HP:0000580Pigmentary retinopathyFrequent (30-79%)
HP:0001257SpasticityFrequent (30-79%)
HP:0001260DysarthriaFrequent (30-79%)
HP:0001347HyperreflexiaFrequent (30-79%)
HP:0002015DysphagiaFrequent (30-79%)
HP:0002359Frequent fallsFrequent (30-79%)
HP:0002454Eye of the tiger anomaly of globus pallidusFrequent (30-79%)
HP:0002533Abnormal posturingFrequent (30-79%)
HP:0002540Inability to walkFrequent (30-79%)
HP:0002659Increased susceptibility to fracturesFrequent (30-79%)
HP:0003552Muscle stiffnessFrequent (30-79%)
HP:0007018Attention deficit hyperactivity disorderFrequent (30-79%)
HP:0007325Generalized dystoniaFrequent (30-79%)
HP:0012675Iron accumulation in brainFrequent (30-79%)
HP:0030051Tip-toe gaitFrequent (30-79%)
HP:0100543Cognitive impairmentFrequent (30-79%)
HP:0000298Mask-like faciesOccasional (5-29%)
HP:0001263Global developmental delayOccasional (5-29%)
HP:0001824Weight lossOccasional (5-29%)
HP:0002179OpisthotonusOccasional (5-29%)
HP:0011951Aspiration pneumoniaOccasional (5-29%)
HP:0012735CoughOccasional (5-29%)
HP:0000618BlindnessVery rare (<1-4%)
HP:0001250SeizureVery rare (<1-4%)

Identifiers

Disease identifiers

FieldValue
Canonical nameclassic pantothenate kinase-associated neurodegeneration
Mondo IDMONDO:0016304
Orphanet216866
UMLSC5679812
MedGen1826057
GARD0017114
Is cancer (heuristic)no

Also known as: NBIA1, classic form · neurodegeneration with brain iron accumulation type 1, classic form · PKAN, classic form

Disease family

This is a subtype of pantothenate kinase-associated neurodegeneration. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › metabolic diseasemineral metabolism diseaseiron metabolism diseaseneurodegeneration with brain iron accumulationpantothenate kinase-associated neurodegenerationclassic pantothenate kinase-associated neurodegeneration

Related subtypes (1): atypical pantothenate kinase-associated neurodegeneration

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.